Tomorrow's Cell
Therapies, Today®
to support and accelerate the development and commercialization of revolutionary therapeutics.
We Simplify the Stem Cell Therapy
Development Process
We Simplify the Stem Cell Therapy
Development Process
Why Pluristyx, powered by panCELLa?
Through the panCELLa platform, Pluristyx provides the expertise and tools to support and accelerate the development and commercialization of revolutionary therapeutics.
With our enlarged portfolio of unique non-modified and genetically engineered iPSC-based technologies, we can assist you at any stage in your product development workflow.
Offering an array of gene editing technologies resulting in unparalleled functional control of commercial products.
Leading provider of gene-edited iPSC and cell therapy solutions, accelerating the path to clinic and providing the best route to commercialization.
Veteran expertise from industry leaders in the field of stem cell biology developmental genetics and cell therapy.
End-to-End Solutions
With our enlarged portfolio of unique non-modified and genetically engineered iPSC-based technologies, we can assist you at any stage in your product development workflow.
Gene Edits
Offering an array of gene editing technologies resulting in unparalleled functional control of commercial products.
Clinical Path iPSC
Leading provider of gene-edited iPSC and cell therapy solutions, accelerating the path to clinic and providing the best route to commercialization.
Scientific Expertise
We have over 50 years of executive experience in development and manufacturing.
Try Before You Buy
Would you like to experience our technology firsthand before committing to a license agreement? We welcome you to have access to our various product offerings before you purchase a commercial license.
Your Problems,
Our Solutions
To overcome any obstacle you’re facing, panCELLa, a novel platform for rapid, efficacious, and high-quality iPSC therapy development, can turn your bold ideas into reality.
Your Problems, Our Solutions
To overcome any obstacle you’re facing, panCELLa, a novel platform for rapid, efficacious, and high-quality iPSC therapy development, can turn your bold ideas into reality.
About Pluristyx
Pluristyx, powered by panCELLa offers an enlarged portfolio of unique and effective non-modified and genetically engineered iPSC-based technologies and related services to provide end-to-end client support throughout the product lifecycle.
About Pluristyx
Pluristyx powered by panCELLa offers an enlarged portfolio of unique and effective non-modified and genetically engineered iPSC-based technologies and related services to provide end-to-end client support throughout the product lifecycle.
About Pluristyx
Pluristyx powered by panCELLa offers an enlarged portfolio of unique and effective non-modified and genetically engineered iPSC-based technologies and related services to provide end-to-end client support throughout the product lifecycle.
Latest News
Stem Genomics Announces Partnership with Pluristyx, Leading One-Stop-Shop Solution Provider for High-Quality Cell-Based Therapies.
Pluristyx and the Advanced Regenerative Manufacturing Institute to Commercialize Clinical-Grade Stem Cells
Pluristyx/panCELLa Become Industry Resource Partner with the California Institute for Regenerative Medicine
The partnership will improve access to clinical-grade genetically-modified induced pluripotent stem cells June 12, 2023 – Seattle – Pluristyx and panCELLa, a merged biotechnology company with offices in Seattle, WA and Toronto, Ontario, CA, are excited to announce their acceptance...